We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IPSC market cap is 196.4M. The company's latest EPS is USD -2.1086 and P/E is -1.44.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.22M | 521k | 1.72M | 99k | 148k |
| Operating Income | -31.74M | -33.31M | -32.08M | -30.86M | -39.85M |
| Net Income | -30.75M | -31.68M | -31.26M | -33.29M | -32.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 5.2M | 2.24M |
| Operating Income | -239.68M | -53.9M | -94.88M | -133.83M | -130.18M |
| Net Income | -238.77M | -53.58M | -95.82M | -130.93M | -136.67M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 511.75M | 486.54M | 456.23M | 417.16M | 397.55M |
| Total Liabilities | 181.55M | 183.81M | 179.05M | 169.59M | 178.32M |
| Total Equity | 330.21M | 302.74M | 277.18M | 247.57M | 219.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 90.9M | 106.78M | 437.38M | 486.54M | 360.69M |
| Total Liabilities | 2.99M | 33.43M | 41.14M | 183.81M | 175.94M |
| Total Equity | -91.86M | -106.41M | 396.24M | 302.74M | 184.75M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 36.96M | 14.05M | -29.22M | -48.47M | -62.12M |
| Investing | -8.86M | -13.13M | 31.34M | 38.31M | 42.53M |
| Financing | 27.06M | 27.16M | 448k | -9.67M | -9.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.77M | -41.27M | -89M | 14.05M | -88.35M |
| Investing | -19.01M | -22.76M | -298.34M | -13.13M | 61.13M |
| Financing | 74.84M | 47.69M | 417.77M | 27.16M | -9.73M |
| Market Cap | 196.4M |
| Price to Earnings Ratio | -1.44 |
| Price to Sales Ratio | 87.83 |
| Price to Cash Ratio | 4.15 |
| Price to Book Ratio | 1.06 |
| Dividend Yield | - |
| Shares Outstanding | 64.82M |
| Average Volume (1 week) | 131.17k |
| Average Volume (1 Month) | 130.64k |
| 52 Week Change | -3.81% |
| 52 Week High | 5.51 |
| 52 Week Low | 1.28 |
| Spread (Intraday) | 0.45 (13.72%) |
| Company Name | Century Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.centurytx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
